Merck Commits $2.9 Billion to Montgomery County Expansion
Article excerpt
Highlighted: the sentence this signal was extracted from
WEST POINT, PA - Merck (NYSE: MRK) plans to invest $2.9 billion in expanding its pharmaceutical research and manufacturing operations in Montgomery County by the end of 2030, backed by $5 million in Pennsylvania state funding as the drugmaker increases its capacity to develop and produce medicines and vaccines. Gov. Josh Shapiro and Pennsylvania Department of Community and Economic Development Secretary Rick Siger disclosed the investment Wednesday, October 14, during a visit to Merck's West Point campus, where officials participated in a ribbon-cutting ceremony for a new research facility. The investment includes $550 million for Merck's ADVANCE facility at West Point and the nearby Springhouse Innovation Park research and development facility. ADVANCE incorporates robotics and artificial intelligence into pharmaceutical research and development, adding technological capabilities to Merck's existing operations in southeastern Pennsylvania. The state offered Merck a $5 million Redevelopment Assistance Capital Program grant to support the initial West Point projects. The expansion will strengthen Merck's manufacturing and research operations in Montgomery County, where the company's West Point campus already produces more than 200 million vaccine doses annually. The investment represents a significant commitment to Pennsylvania's pharmaceutical manufacturing sector, which has...
Keep reading with a free account
The rest of this article, and every signal for Merck, is in your free account.
